BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31506324)

  • 1. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
    Dai Y; Li P; Wang Z; Liang F; Yang F; Fang L; Huang Y; Huang S; Zhou J; Wang D; Cui L; Wang K
    J Med Genet; 2020 Feb; 57(2):109-120. PubMed ID: 31506324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
    Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM
    Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Application of Optical Genome Mapping for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.
    Shim Y; Seo J; Lee ST; Choi JR; Choi YC; Shin S; Park HJ
    Ann Lab Med; 2024 Sep; 44(5):437-445. PubMed ID: 38724225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
    Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
    Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges.
    Efthymiou S; Lemmers RJLF; Vishnu VY; Dominik N; Perrone B; Facchini S; Vegezzi E; Ravaglia S; Wilson L; van der Vliet PJ; Mishra R; Reyaz A; Ahmad T; Bhatia R; Polke JM; Srivastava MP; Cortese A; Houlden H; van der Maarel SM; Hanna MG; Bugiardini E
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping.
    Guruju NM; Jump V; Lemmers R; Van Der Maarel S; Liu R; Nallamilli BR; Shenoy S; Chaubey A; Koppikar P; Rose R; Khadilkar S; Hegde M
    Neurol Genet; 2023 Dec; 9(6):e200107. PubMed ID: 38021397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?
    Barat-Houari M; Nguyen K; Bernard R; Fernandez C; Vovan C; Bareil C; Khau Van Kien P; Thorel D; Tuffery-Giraud S; Vasseur F; Attarian S; Pouget J; Girardet A; Lévy N; Claustres M
    Eur J Hum Genet; 2010 May; 18(5):533-8. PubMed ID: 19935833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy.
    Kovanda A; Lovrečić L; Rudolf G; Babic Bozovic I; Jaklič H; Leonardis L; Peterlin B
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Van Overveld PG; Sandkuijl LA; Vrieling H; Padberg GW; Frants RR; van der Maarel SM
    Am J Hum Genet; 2004 Jul; 75(1):44-53. PubMed ID: 15154112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
    Lemmers RJLF; Butterfield R; van der Vliet PJ; de Bleecker JL; van der Pol L; Dunn DM; Erasmus CE; D'Hooghe M; Verhoeven K; Balog J; Bigot A; van Engelen B; Statland J; Bugiardini E; van der Stoep N; Evangelista T; Marini-Bettolo C; van den Bergh P; Tawil R; Voermans NC; Vissing J; Weiss RB; van der Maarel SM
    Brain; 2024 Feb; 147(2):414-426. PubMed ID: 37703328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
    Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
    Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genetic analysis of facioscapulohumeral muscular dystrophy by Nanopore long-read whole-genome sequencing.
    Huang M; Zhang Q; Jiao J; Shi J; Xu Y; Zhang C; Zhou R; Liu W; Liang Y; Chen H; Wang Y; Xu Z; Hu P
    J Transl Med; 2024 May; 22(1):451. PubMed ID: 38741136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of facioscapulohumeral muscular dystrophy.
    Tupler R; Gabellini D
    Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.
    van der Maarel SM; Deidda G; Lemmers RJ; van Overveld PG; van der Wielen M; Hewitt JE; Sandkuijl L; Bakker B; van Ommen GJ; Padberg GW; Frants RR
    Am J Hum Genet; 2000 Jan; 66(1):26-35. PubMed ID: 10631134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophy.
    Pope BD; Tsumagari K; Battaglia D; Ryba T; Hiratani I; Ehrlich M; Gilbert DM
    PLoS One; 2011; 6(11):e27413. PubMed ID: 22096571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unifying genetic model for facioscapulohumeral muscular dystrophy.
    Lemmers RJ; van der Vliet PJ; Klooster R; Sacconi S; Camaño P; Dauwerse JG; Snider L; Straasheijm KR; van Ommen GJ; Padberg GW; Miller DG; Tapscott SJ; Tawil R; Frants RR; van der Maarel SM
    Science; 2010 Sep; 329(5999):1650-3. PubMed ID: 20724583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping.
    Jiang J; Cai X; Qu H; Yao Q; He T; Yang M; Zhou H; Zhang X
    Front Neurol; 2024; 15():1258831. PubMed ID: 38361638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size.
    Statland JM; Sacconi S; Farmakidis C; Donlin-Smith CM; Chung M; Tawil R
    Neurology; 2013 Mar; 80(13):1247-50. PubMed ID: 23446679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.
    Ricci G; Zatz M; Tupler R
    Curr Mol Med; 2014; 14(8):1052-1068. PubMed ID: 25323867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.